As of 2024-12-12, the EV/EBITDA ratio of Meridian Bioscience Inc (VIVO) is
13.95.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VIVO's latest enterprise value
is 1,438.51 mil USD. VIVO's TTM EBITDA according to its financial statements is
103.12 mil USD. Dividing these 2
quantities gives us the above VIVO EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
9.8x - 13.8x |
11.8x |
| Forward P/E multiples |
13.4x - 17.0x |
15.6x |
| Fair Price |
23.97 - 33.57 |
28.29 |
| Upside |
-29.4% - -1.2% |
-16.7% |